Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer

Autor Parekh, Parag, Kamble, Sanchit, Zhao, Nianxi, Zeng, Zihua, Portier, Bryce P., Zu, Youli
Vydáno 2013

HER4 expression status correlates with improved outcome in both neoadjuvant and adjuvant Trastuzumab treated invasive breast carcinoma

Autor Portier, Bryce P, Minca, Eugen C, Wang, Zhen, Lanigan, Christopher, Gruver, Aaron M, Downs-Kelly, Erinn, Budd, G Thomas, Tubbs, Raymond R
Vydáno 2013

Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells

Autor Fiskus, Warren, Sharma, Sunil, Shah, Bhavin, Portier, Bryce P., Devaraj, Santhana G. T., Liu, Ka, Iyer, Swaminathan P., Bearss, David, Bhalla, Kapil N.
Vydáno v Leukemia (2014)

BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITD

Autor Fiskus, Warren, Sharma, Sunil, Qi, Jun, Shah, Bhavin, Devaraj, Santhana G. T., Leveque, Christopher, Portier, Bryce P., Iyer, Swaminathan, Bradner, James E., Bhalla, Kapil N.
Vydáno 2014

Proficiency testing of standardized samples shows very high inter-laboratory agreement for clinical next generation sequencing-based oncology assays

Autor Merker, Jason D., Devereaux, Kelly, Iafrate, A. John, Kamel-Reid, Suzanne, Kim, Annette S., Moncur, Joel T., Montgomery, Stephen B, Nagarajan, Rakesh, Portier, Bryce P., Routbort, Mark J., Smail, Craig, Surrey, Lea F., Vasalos, Patricia, Lazar, Alexander J., Lindeman, Neal I.
Vydáno v Arch Pathol Lab Med (2018)